AG Campbell issued the following statement in response to today’s ruling by the Supreme Court of the United States in Louisiana v. FDA maintaining access to mifepristone, a safe and effective abortion medication: 

“Today’s decision preserves access to mifepristone as critical reproductive healthcare while this litigation continues. Mifepristone is one of the most common forms of safe and effective abortion care in Massachusetts and across the country, including for patients who rely on telehealth to access timely care. This decision ensures patients can continue making personal medical decisions without political interference. My office will continue to fight to preserve access in the face of this lawsuit and other threats.”  – AG Campbell